Purpose
to support bidirectional resistance profiling of TMC278, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and approved NNRTIs
Grantee
Division
Global Health
Date
JULY 2011
Region served
GLOBAL
Committed amount
$1,194,394
Grant topic
HIV
Duration (months)
74
Grantee location
Pittsburgh, Pennsylvania, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.